Financials in USD. Standardized financial statements.
A compact view of how Avadel Pharmaceuticals plc turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $169.12M | $27.96M | $0 | $0 | $22.33M | $59.22M | $103.27M | $172.74M | $150.25M | $173.21M |
| Revenue Growth? | +504.8% | 0.0% | 0.0% | -100.0% | -62.3% | -42.7% | -40.2% | +15.0% | -13.3% | 0.0% |
| Cost of Revenue? | $15.28M | $846,000 | $0 | $0 | $5.74M | $12.13M | $17.52M | $16.30M | $13.25M | $10.92M |
| Gross Profit? | $153.84M | $27.12M | $0 | $0 | $16.59M | $47.09M | $85.75M | $156.44M | $137.00M | $162.29M |
| Gross Margin? | +91.0% | +97.0% | 0.0% | 0.0% | +74.3% | +79.5% | +83.0% | +90.6% | +91.2% | +93.7% |
| Operating Expenses? | $196.24M | $164.97M | $98.56M | $85.55M | $10.78M | $71.20M | $146.31M | $96.74M | $92.68M | $59.88M |
| Operating Income? | -$42.40M | -$137.85M | -$98.56M | -$85.55M | $5.82M | -$24.11M | -$104.93M | $88.30M | -$4.96M | $71.45M |
| EBITDA? | -$35.57M | -$149.13M | -$97.60M | -$82.39M | $9.60M | -$23.61M | -$95.14M | $65.89M | $5.73M | $115.54M |
| Income Before Tax | -$49.08M | -$160.78M | -$111.44M | -$93.14M | -$5.08M | -$38.58M | -$113.20M | $91.47M | -$9.72M | $78.39M |
| Income Tax Expense | -$247,000 | -$501,000 | $26.02M | -$15.82M | -$12.11M | -$5.36M | -$17.89M | $24.21M | $31.56M | $37.73M |
| Net Income? | -$48.83M | -$160.28M | -$137.46M | -$77.33M | $7.03M | -$33.23M | -$95.30M | $67.25M | -$41.28M | $40.66M |
| EPS? | $-0.51 | $-2.00 | $-2.29 | $-1.32 | $0.13 | $-0.89 | $-2.55 | $1.66 | $-1.00 | $1.00 |
| Diluted EPS? | $-0.51 | $-2.00 | $-2.29 | $-1.32 | $0.13 | $-0.89 | $-2.55 | $1.61 | $-1.00 | $0.93 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality